← AtriCure, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $155.1m |
$174.7m
+12.64%
|
$201.6m
+15.40%
|
$230.8m
+14.47%
|
$206.5m
-10.52%
|
$274.3m
+32.83%
|
$330.4m
+20.43%
|
$399.2m
+20.84%
|
$465.3m
+16.55%
|
$534.5m
+14.88%
|
$569.6m
+6.57%
|
|
| Cost of Revenue | $44.0m |
$48.6m
+10.33%
|
$785k
-98.38%
|
$635k
-19.11%
|
$655k
+3.15%
|
$68.5m
+10353.28%
|
$84.4m
+23.32%
|
$98.9m
+17.10%
|
$117.8m
+19.12%
|
$133.7m
+13.56%
|
$135.0m
+0.95%
|
|
| Gross Profit | $111.1m |
$126.2m
+13.56%
|
$147.1m
+16.61%
|
$170.3m
+15.78%
|
$149.3m
-12.34%
|
$205.9m
+37.88%
|
$245.9m
+19.47%
|
$300.4m
+22.13%
|
$347.5m
+15.70%
|
$400.8m
+15.32%
|
$434.6m
+8.44%
|
|
| Interest Income (Expense), Net | — | — | $3.1m | — | — | — | — | — | — | — | $4.9m | |
| Research and Development Expense | $35.8m | $34.1m | $34.7m | $41.2m | $43.1m | $48.5m | $57.3m | $73.9m | $96.2m | $99.2m | $98.0m | |
| Selling, General and Administrative Expense | $106.4m | $117.0m | $129.5m | $162.2m | $150.5m | $204.6m | $231.3m | $253.1m | $291.4m | $311.0m | $323.7m | |
| Amortization of Intangible Assets | $1.6m | $1.4m | $1.5m | $1.9m | $1.7m | $2.9m | $3.7m | $5.4m | $7.5m | $8.4m | — | |
| Operating Expenses | $142.2m | $151.1m | $164.2m | $203.5m | $193.5m | $150.7m | $288.6m | $327.1m | $387.5m | $410.2m | $421.7m | |
| Operating Income (Loss) | ($31.1m) |
($25.0m)
+19.78%
|
($17.1m)
+31.43%
|
($33.1m)
-93.39%
|
($44.2m)
-33.55%
|
$55.2m
+224.81%
|
($42.7m)
-177.29%
|
($26.7m)
+37.47%
|
($40.0m)
-49.96%
|
($9.4m)
+76.39%
|
$12.9m
+236.45%
|
|
| Foreign Currency Transaction Gain (Loss), before Tax | ($407k) | $173k | ($165k) | ($181k) | — | — | — | — | — | — | — | |
| Gain (Loss) on Investments | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| Other Nonoperating Income (Expense) | ($586k) | $138k | ($183k) | ($160k) | ($24k) | ($366k) | ($537k) | ($31k) | ($326k) | $683k | — | |
| Interest Expense (non-operating) | $1.8m | $2.3m | $4.6m | $4.1m | $4.9m | $4.9m | $5.0m | $6.9m | $6.4m | $5.9m | $5.6m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | ($27.3m) | ($19.4m) | ($13.4m) | ($28.0m) | ($43.2m) | $55.7m | ($38.0m) | ($17.8m) | ($37.0m) | ($8.8m) | $12.1m | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | ($33.3m) | ($26.9m) | ($20.9m) | ($35.0m) | ($48.0m) | $50.4m | ($46.2m) | ($29.8m) | ($43.7m) | ($10.2m) | $12.1m | |
| Current Income Tax Expense (Benefit) | $40k | $116k | $175k | $173k | $126k | $167k | $260k | $606k | $1.0m | $1.3m | $1.5m | |
| Income Tax Expense (Benefit) | $40k | $14k | $226k | $199k | $114k | $188k | $268k | $591k | $1.0m | $1.3m | $1.5m | |
| Net Income (Loss) Attributable to Parent | ($33.3m) |
($26.9m)
+19.34%
|
($21.1m)
+21.40%
|
($35.2m)
-66.50%
|
($48.2m)
-36.83%
|
$50.2m
+204.24%
|
($46.5m)
-192.56%
|
($30.4m)
+34.49%
|
($44.7m)
-46.85%
|
($11.4m)
+74.39%
|
$10.6m
+192.17%
|
|
| Earnings Per Share, Basic | — | — | — | ($0.94) | ($1.14) | $1.11 | ($1.02) | ($0.66) | ($0.95) | ($0.24) | $0.22 | |
| Earnings Per Share, Diluted | — | — | — | ($0.94) | ($1.14) | $1.09 | ($1.02) | ($0.66) | ($0.95) | ($0.24) | $0.21 | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | — | 37.6m | 42.1m | 45.1m | 45.7m | 46.3m | 47.0m | 47.8m | 48.2m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | 37.6m | 42.1m | 46.0m | 45.7m | 46.3m | 47.0m | 47.8m | 48.5m |